{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T11:40:04Z","timestamp":1716982804629},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["patient-research.elsevier.com","transplantation-proceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.transproceed.2014.02.016","type":"journal-article","created":{"date-parts":[[2014,7,9]],"date-time":"2014-07-09T01:31:46Z","timestamp":1404869506000},"page":"2414-2417","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["First Case Report of De Novo Ulcerative Colitis Developing After Orthotopic Liver Transplantation Successfully Treated by Granulocyte and Monocyte Apheresis"],"prefix":"10.1016","volume":"46","author":[{"given":"S.","family":"Ihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Yamaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Kokudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2014.02.016_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2036.2012.05141.x","article-title":"The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series","volume":"36","author":"Sandhu","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2014.02.016_bib2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1365-2036.2012.05067.x","article-title":"The effects of liver transplantation on the clinical course of colitis in ulcerative colitis patients with primary sclerosing cholangitis","volume":"35","author":"Navaneethan","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2014.02.016_bib3","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/j.1572-0241.2006.00624.x","article-title":"Five cases of de novo inflammatory bowel disease after orthotopic liver transplantation","volume":"101","author":"W\u00f6rns","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.transproceed.2014.02.016_bib4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2009.727","article-title":"Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee","volume":"105","author":"Kornbluth","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.transproceed.2014.02.016_bib5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.2010.224154","article-title":"Guidelines for the management of inflammatory bowel disease in adults","volume":"60","author":"Mowat","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.transproceed.2014.02.016_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.crohns.2007.11.002","article-title":"European evidence-based consensus on the management of ulcerative colitis: current management","volume":"2","author":"Travis","year":"2008","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.transproceed.2014.02.016_bib7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.crohns.2011.04.011","article-title":"Fulminant ulcerative colitis despite maximal immunosuppression following liver transplantation: a case report and literature review","volume":"5","author":"Pan","year":"2011","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.transproceed.2014.02.016_bib8","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s10620-009-0845-x","article-title":"Clinical effectiveness of selective granulocyte, monocyte adsorptive apheresis with the Adacolumn device in ulcerative colitis","volume":"55","author":"Habermalz","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.transproceed.2014.02.016_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CEG.S33275","article-title":"Therapeutic landscape for ulcerative colitis: where is the Adacolumn system and where should it be?","volume":"6","author":"Vecchi","year":"2013","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.transproceed.2014.02.016_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jca.1000","article-title":"Safety and efficacy of granulocytes and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study","volume":"16","author":"Shimoyama","year":"2001","journal-title":"J\u00a0Clin Apher"},{"key":"10.1016\/j.transproceed.2014.02.016_bib11","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.3748\/wjg.v11.i44.7001","article-title":"Open-label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis","volume":"11","author":"Kruis","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.transproceed.2014.02.016_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000321911","article-title":"Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants","volume":"84","author":"Yoshino","year":"2011","journal-title":"Digestion"},{"key":"10.1016\/j.transproceed.2014.02.016_bib13","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.transproceed.2012.06.040","article-title":"Management of hepatitis C virus infection in liver transplantation with adacolumn apheresis","volume":"44","author":"Novelli","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2014.02.016_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1155\/2010\/830291","article-title":"The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation \u2013 a single-centre experience","volume":"24","author":"Moncrief","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.transproceed.2014.02.016_bib15","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/lt.20500","article-title":"Diarrhea in liver transplant recipients: etiology and management","volume":"8","author":"Ginsburg","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2014.02.016_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00042737-200203000-00005","article-title":"Colorectal disease in liver allograft recipients: a clinicopathological study with follow-up","volume":"14","author":"Wong","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.transproceed.2014.02.016_bib17","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.transproceed.2012.01.007","article-title":"De novo ulcerative colitis and autoimmune hepatitis after living related liver transplantation from cytomegalovirus-positive donor to cytomegalovirus-negative recipient: a case report","volume":"44","author":"Sakamoto","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2014.02.016_bib18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.gtc.2009.07.003","article-title":"Clostridium difficile and inflammatory bowel disease","volume":"38","author":"Ananthakrishnan","year":"2009","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.transproceed.2014.02.016_bib19","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3892\/etm.2012.718","article-title":"Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease","volume":"4","author":"Wang","year":"2012","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.transproceed.2014.02.016_bib20","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/gut.2004.040675","article-title":"Chronic hepatitis B reactivation following infliximab therapy in Crohn\u2019s disease patients: need for primary prophylaxis","volume":"53","author":"Esteve","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.transproceed.2014.02.016_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1874226201003010027","article-title":"A\u00a0review of hepatitis B management in pre- and post-liver transplant recipients","volume":"3","author":"Mukherjee","year":"2010","journal-title":"Open Immunol J"},{"key":"10.1016\/j.transproceed.2014.02.016_bib22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1744-9987.1998.tb00091.x","article-title":"A\u00a0role of granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis","volume":"2","author":"Kashiwagi","year":"1998","journal-title":"Ther Apher"},{"key":"10.1016\/j.transproceed.2014.02.016_bib23","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1440-1746.2012.07119.x","article-title":"Current status and future perspectives of leukocytapheresis for inflammatory bowel disease","volume":"27","author":"Fukunaga","year":"2012","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.transproceed.2014.02.016_bib24","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.gastro.2008.04.023","article-title":"A\u00a0randomized, double-blind, sham-controlled study of granulocyte\/monocyte apheresis for active ulcerative colitis","volume":"135","author":"Sands","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2014.02.016_bib25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/jca.20315","article-title":"The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study","volume":"26","author":"Passalacqua","year":"2011","journal-title":"J\u00a0Clin Apher"},{"key":"10.1016\/j.transproceed.2014.02.016_bib26","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/ibd.20505","article-title":"Selective white cell apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse","volume":"14","author":"Maiden","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.transproceed.2014.02.016_bib27","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.dld.2009.09.001","article-title":"Sustained remission after steroids and leukocyte- apheresis induced response in steroid-dependent ulcerative colitis: results at 1 year","volume":"42","author":"Cabriada","year":"2010","journal-title":"Dig Liver Dis"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134514001377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134514001377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T11:03:30Z","timestamp":1716980610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134514001377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0041134514001377"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2014.02.016","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First Case Report of De Novo Ulcerative Colitis Developing After Orthotopic Liver Transplantation Successfully Treated by Granulocyte and Monocyte Apheresis","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2014.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}